These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38554998)

  • 41. Mainstreaming contraceptive services in managed care--five states' experiences.
    Gold RB; Darroch JE; Frost JJ
    Fam Plann Perspect; 1998; 30(5):204-11. PubMed ID: 9782042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of behavioral health integration in Medicaid managed care on access to mental health and primary care services-Evidence from early adopters.
    McConnell KJ; Edelstein S; Hall J; Levy A; Danna M; Cohen DJ; Lindner S; Unützer J; Zhu JM
    Health Serv Res; 2023 Jun; 58(3):622-633. PubMed ID: 36635871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Nonquantitative Treatment Limits for Specialty Behavioral Health Care.
    Thalmayer AG; Harwood JM; Friedman S; Azocar F; Watson LA; Xu H; Ettner SL
    Health Serv Res; 2018 Dec; 53(6):4584-4608. PubMed ID: 29740807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the US.
    Robst J
    Pharmacoeconomics; 2012 May; 30(5):387-96. PubMed ID: 22316397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medicaid managed care and the family planning free-choice exemption: beyond the freedom to choose.
    Rosenbaum S; Shin PW; Mauskopf A; Zuvekas A
    J Health Polit Policy Law; 1997 Oct; 22(5):1191-214. PubMed ID: 9394245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Carving in Pharmacy Benefits on Utilization and Costs.
    Parekh N; Papa S; Drnach A; Spiegel L; Huang Y; Manolis C; Good CB
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1317-1324. PubMed ID: 32996397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes for medicaid clients with substance abuse problems before and after managed care.
    McFarland BH; Deck DD; McCamant LE; Gabriel RM; Bigelow DA
    J Behav Health Serv Res; 2005; 32(4):351-67. PubMed ID: 16215446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Savings from a Medicaid carve-out for mental health and substance abuse services in Massachusetts.
    Frank RG; McGuire TG
    Psychiatr Serv; 1997 Sep; 48(9):1147-52. PubMed ID: 9285974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral health issue brief: Medicaid managed care and behavioral health: an overview of 1915(b) and statewide 1115 waivers.
    Perez S
    Issue Brief Health Policy Track Serv; 1998 Dec; ():1-18. PubMed ID: 11073402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of outpatient use of mental health services for Medicaid beneficiaries under a prepaid mental health carve-out.
    Liu CF; Manning WG; Christianson JB; Stoner T; Lurie N; Gray DZ; Popkin M
    Adm Policy Ment Health; 1999 Jul; 26(6):401-15. PubMed ID: 10615742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Managed behavioral health care and supply-side economics. 1998 Carl Taube Lecture.
    Scheffler RM
    J Ment Health Policy Econ; 1999 Mar; 2(1):21-28. PubMed ID: 11967404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer.
    Hernandez I; Gellad WF
    J Manag Care Spec Pharm; 2020 Feb; 26(2):154-159. PubMed ID: 32011961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managed care's impact on Medicaid financing for early intervention services.
    Fox HB; McManus MA; Almeida RA
    Health Care Financ Rev; 1998; 20(1):59-72. PubMed ID: 10387426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multi-site study of Medicaid-funded managed care versus fee-for-service plans' effects on mental health service utilization of children with severe emotional disturbance.
    Cook JA; Heflinger CA; Hoven CW; Kelleher KJ; Mulkern V; Paulson RI; Stein-Seroussi A; Fitzgibbon G; Burke-Miller J; Williams M; Kim JB
    J Behav Health Serv Res; 2004; 31(4):384-402. PubMed ID: 15602140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beyond the freedom to choose. Medicaid, managed care, and family planning.
    Rosenbaum S; Shin P; Mauskopf A; Fund K; Stern G; Zuvekas A
    West J Med; 1995 Sep; 163(3 Suppl):33-8. PubMed ID: 7571601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Race/ethnicity and geographic access to Medicaid substance use disorder treatment facilities in the United States.
    Cummings JR; Wen H; Ko M; Druss BG
    JAMA Psychiatry; 2014 Feb; 71(2):190-6. PubMed ID: 24369387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of drug treatment of childhood persistent asthma in Maryland medicaid recipients in transition from managed fee for service to managed capitation.
    Singhal PK; Zuckerman I; Stuart B; Magder L; Rubin H
    J Manag Care Pharm; 2007 May; 13(4):310-8. PubMed ID: 17506597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peer support to reduce readmission in Medicaid-enrolled adults with substance use disorder.
    Hutchison SL; MacDonald-Wilson KL; Karpov I; Herschell AD; Carney T
    J Subst Abuse Treat; 2023 Jan; 144():108901. PubMed ID: 36302294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Nebraska Medicaid managed behavioral health care initiative: impacts on utilization, expenditures, and quality of care for mental health.
    Bouchery E; Harwood H
    J Behav Health Serv Res; 2003; 30(1):93-108. PubMed ID: 12633006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Florida's Medicaid mental health carve-out: lessons from the first years of implementation.
    Ridgely MS; Giard J; Shern D
    J Behav Health Serv Res; 1999 Nov; 26(4):400-15. PubMed ID: 10565101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.